The good news among Corona Kahir, the country may soon have five new vaccines
Coronavirus Vaccines In India: Two coronavirus vaccines - Covaxin and Covishield - are currently approved for emergency use in India. By October 5 more vaccines could arrive in the country.
Amid reports of a shortage of the Covid-19 vaccine, the central government has taken steps to increase vaccine production. News agency ANI quoted sources as saying that 5 more corona vaccines will be available in the country by October. At present, only Covishield and Covacin are being produced in India. The Sputnik V vaccine, developed in Russia, could be approved next June.
Which five vaccines are coming?
Five other vaccines will be available in India by the third quarter of 2021, ANI quoted sources as saying. These five vaccines are as follows.
Sputnik V vaccine
Johnson & Johnson Vaccine
Novavax vaccine
Zydus cadilla vaccine
Coronavirus Vaccines In India |
Amid reports of a shortage of the Covid-19 vaccine, the central government has taken steps to increase vaccine production. News agency ANI quoted sources as saying that 5 more corona vaccines will be available in the country by October. At present, only Covishield and Covacin are being produced in India. The Sputnik V vaccine, developed in Russia, could be approved next June.
Which five vaccines are coming?
Five other vaccines will be available in India by the third quarter of 2021, ANI quoted sources as saying. These five vaccines are as follows.
Sputnik V vaccine
Johnson & Johnson Vaccine
Novavax vaccine
Zydus cadilla vaccine
Click here To read Gujarati
When will the vaccine arrive?
Citing government sources, the NIA said Sputnik V could be available in India by June. If all goes well, Johnson & Johnson's vaccine will arrive by August. The Zydus Cadillac vaccine is also expected to arrive in August. Novavax may be available in India till September and October.
Sputnik V will get the first approval
The vaccine Sputnik V, developed in Russia, may be approved for emergency use within the next 10 days. The Russian Direct Investment Fund (RDIF) has entered into agreements with several Indian farm companies to develop vaccines. In India, 850 million doses of this vaccine can be produced every year.
No comments:
Post a Comment